血浆用于预防和治疗创伤与脓毒症中的内皮糖萼降解
本文为叙述性综述,围绕内皮糖萼在创伤和脓毒症中的损伤机制,以及血浆作为预防和治疗糖萼降解的潜在疗法展开。血浆是出血复苏中恢复凝血因子的既定疗法,同时含有1-磷酸鞘氨醇、抗凝血酶和脂联素等生物活性成分,可能保护和恢复内皮糖萼。目前支持血浆用于糖萼降解的证据均为非临床基础科学或探索性研究,尚无经过验证的疗法。综述还回顾了血浆输注相关不良事件及现代输血预防措施,结论认为血浆可能具有预防和治疗创伤与脓毒症中内皮糖萼降解的潜力,需要进一步研究。
要点
- 血浆是出血复苏中恢复凝血因子的既定疗法,但用于内皮糖萼降解的证据仅为非临床基础科学或探索性研究。
- 血浆含有1-磷酸鞘氨醇、抗凝血酶和脂联素等生物活性成分,可能保护和恢复内皮糖萼,从而帮助维持或恢复血管稳态。
- 创伤和脓毒症导致内皮糖萼降解,可引发微血管功能障碍和器官损伤,目前尚无经过验证的预防或治疗糖萼降解的疗法。
- 综述讨论了血浆输注相关不良事件及现代输血预防措施,这些措施提高了血浆输注的安全性。
- 作者结论认为文献提示血浆可能具有预防和治疗创伤与脓毒症中内皮糖萼降解的潜力,需要进一步研究。
适用人群与场景
- 创伤患者和脓毒症患者,涉及内皮糖萼降解的预防和治疗场景。
研究设计与关键结果
- 叙述性综述,讨论创伤和脓毒症中导致内皮糖萼损伤的重叠疾病机制,并介绍血浆输注作为预防和治疗内皮糖萼降解的潜在疗法。
- 综述回顾了血浆作为内皮糖萼降解探索性疗法在创伤和脓毒症中的文献,并审查了血浆及其他血液制品输注相关的不良事件及现代输血预防措施。
证据类型、等级与局限
- 证据类型:叙述性综述。
- 总体而言,提示血浆作为内皮糖萼降解疗法的文献均为非临床基础科学或探索性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 血浆是出血复苏中恢复凝血因子的既定疗法,原文未据此改变该做法。
- 对于创伤和脓毒症中内皮糖萼降解的预防和治疗,目前尚无经过验证的疗法,血浆在该场景下的作用仅为文献提示的潜在可能,需要进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The endothelial glycocalyx, a gel-like layer that lines the luminal surface of blood vessels, is composed of proteoglycans, glycoproteins, and glycosaminoglycans. The endothelial glycocalyx plays an essential role in vascular homeostasis, and its degradation in trauma and sepsis can lead to microvascular dysfunction and organ injury. While there are no proven therapies for preventing or treating endothelial glycocalyx degradation, some initial literature suggests that plasma may have a therapeutic role in trauma and sepsis patients. Overall, the literature suggesting the use of plasma as a therapy for endothelial glycocalyx degradation is non-clinical basic science or exploratory. Plasma is an established therapy in the resuscitation of patients with hemorrhage for restoration of coagulation factors. However, plasma also contains other bioactive components, including sphingosine-1 phosphate, antithrombin, and adiponectin, which may protect and restore the endothelial glycocalyx, thereby helping to maintain or restore vascular homeostasis. This narrative review begins by describing the endothelial glycocalyx in health and disease: we discuss the overlapping disease mechanisms in trauma and sepsis that lead to its damage and introduce plasma transfusion as a potential therapy for prevention and treatment of endothelial glycocalyx degradation. Second, we review the literature on plasma as an exploratory therapy for endothelial glycocalyx degradation in trauma and sepsis. Third, we discuss the safety of plasma transfusion by reviewing the adverse events associated with plasma and other blood product transfusions, and we examine modern transfusion precautions that have enhanced the safety of plasma transfusion. We conclude that the literature proposes that plasma may have the potential to prevent and treat endothelial glycocalyx degradation in trauma and sepsis, indicating the need for further research.
参考来源
- Kravitz MS, Kattouf N, Stewart IJ, et al. Plasma for prevention and treatment of glycocalyx degradation in trauma and sepsis. Crit Care. 2024. PMID: 39033135. doi:10.1186/s13054-024-05026-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。